---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021880"
form_type: "8-K"
ticker: "OCEA"
cik: "0001869974"
company_name: "Ocean Biomedical, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:28:56.876953+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Ocean Biomedical receives Nasdaq non-compliance notice for late Q1 2024 10-Q filing

## Summary
- Nasdaq notice received May 22, 2024 due to failure to file Form 10-Q for period ended March 31, 2024.
- Company must submit a plan to regain compliance by June 14, 2024, and file delinquent 10-Q by October 14, 2024.
- No immediate effect on listing or trading of OCEA common stock or OCEAW warrants, but further delays could impact.
- Ocean Biomedical cites previously disclosed delays from its 2023 10-K as the cause.
- Company intends to file the delinquent Form 10-Q as soon as practicable.

## SEC filing metadata
- accession: 0001493152-24-021880
- form_type: 8-K
- ticker: OCEA
- cik: 0001869974
- company_name: Ocean Biomedical, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/0001493152-24-021880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1869974/000149315224021880/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021880
- JSON: https://secwatch.observer/filing/0001493152-24-021880.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.